Communicating Benefits from Vaccines Beyond Preventing Infectious Diseases
- PMID: 32583334
- PMCID: PMC7452969
- DOI: 10.1007/s40121-020-00312-7
Communicating Benefits from Vaccines Beyond Preventing Infectious Diseases
Abstract
Despite immunisation being one of the greatest medical success stories of the twentieth century, there is a growing lack of confidence in some vaccines. Improving communication about the direct benefits of vaccination as well as its benefits beyond preventing infectious diseases may help regain this lost confidence. A conference was organised at the Fondation Merieux in France to discuss what benefits could be communicated and how innovative digital initiatives can used for communication. During this meeting, a wide range of indirect benefits of vaccination were discussed. For example, influenza vaccination can reduce hospitalisations and deaths in older persons with diabetes by 45% and 38%, respectively, but the link between influenza and complications from underlying chronic non-communicable diseases such as diabetes is frequently underestimated. Vaccination can reduce antimicrobial resistance (AMR), which is growing, by reducing the incidence of infectious disease (though direct and indirect or herd protection), by reducing the number of circulating AMR strains, and by reducing the need for antimicrobial use. Disease morbidity and treatment costs in the elderly population are likely to rise substantially, with the ageing global population. Healthy ageing and life-course vaccination approaches can reduce the burden of vaccine-preventable diseases, such as seasonal influenza and pneumococcal diseases, which place a significant burden on individuals and society, while improving quality of life. Novel disease surveillance systems based on information from Internet search engines, mobile phone apps, social media, cloud-based electronic health records, and crowd-sourced systems, contribute to improved awareness of disease burden. Examples of the role of new techniques and tools to process data generated by multiple sources, such as artificial intelligence, to support vaccination programmes, such as influenza and dengue, were discussed. The conference participants agreed that continual efforts are needed from all stakeholders to ensure effective, transparent communication of the full benefits and risks of vaccination.
Keywords: Communication; Direct benefits; Indirect benefits; Vaccination; Vaccines.
Conflict of interest statement
Emma-Pascale Chevalier-Cottin and Nansa Burlet are employed by Sanofi Pasteur. Myint Tin Tin Htar is employed by Pfizer. Hayley Ashbaugh, Nicholas Brooke, Gaetan Gavazzi and Mauricio Santillana declare that they have no conflict of interest.
Figures
Similar articles
-
Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference.Pan Afr Med J. 2016 Feb 29;23:53. doi: 10.11604/pamj.2016.23.53.9097. eCollection 2016. Pan Afr Med J. 2016. PMID: 27217879 Free PMC article.
-
Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.Hum Vaccin Immunother. 2022 Nov 30;18(5):2058304. doi: 10.1080/21645515.2022.2058304. Epub 2022 Apr 29. Hum Vaccin Immunother. 2022. PMID: 35486410 Free PMC article.
-
Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.BMC Infect Dis. 2012 Sep 7;12:207. doi: 10.1186/1471-2334-12-207. BMC Infect Dis. 2012. PMID: 22954038 Free PMC article. Review.
-
Vaccine acceptance: Science, policy, and practice in a 'post-fact' world.Vaccine. 2019 Jan 29;37(5):677-682. doi: 10.1016/j.vaccine.2018.12.014. Epub 2019 Jan 4. Vaccine. 2019. PMID: 30616955
-
Assessment of vaccine candidates for persons aged 50 and older: a review.BMC Geriatr. 2013 Apr 15;13:32. doi: 10.1186/1471-2318-13-32. BMC Geriatr. 2013. PMID: 23586926 Free PMC article. Review.
Cited by
-
Healthy ageing: Herpes zoster infection and the role of zoster vaccination.NPJ Vaccines. 2023 Nov 28;8(1):184. doi: 10.1038/s41541-023-00757-0. NPJ Vaccines. 2023. PMID: 38017011 Free PMC article. Review.
-
Effect of measles prevalence and vaccination coverage on other disease burden: evidence of measles immune amnesia in 46 African countries.Hum Vaccin Immunother. 2021 Dec 2;17(12):5361-5366. doi: 10.1080/21645515.2021.2013078. Epub 2021 Dec 29. Hum Vaccin Immunother. 2021. PMID: 34965183 Free PMC article.
-
Association between seasonal influenza vaccination and antimicrobial use in Japan from the 2015-16 to 2020-21 seasons: from the VENUS study.J Antimicrob Chemother. 2023 Dec 1;78(12):2976-2982. doi: 10.1093/jac/dkad340. J Antimicrob Chemother. 2023. PMID: 37897719 Free PMC article.
-
Associations of infections and vaccines with Alzheimer's disease point to a role of compromised immunity rather than specific pathogen in AD.Exp Gerontol. 2024 Jun 1;190:112411. doi: 10.1016/j.exger.2024.112411. Epub 2024 Apr 2. Exp Gerontol. 2024. PMID: 38548241 Free PMC article.
-
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges-A Narrative Review.Pharmaceuticals (Basel). 2024 Jun 19;17(6):807. doi: 10.3390/ph17060807. Pharmaceuticals (Basel). 2024. PMID: 38931474 Free PMC article. Review.
References
-
- World Health Organisation. Health topics: Vaccines 2019. https://www.who.int/topics/vaccines/en/. Accessed 9 Nov 2019.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources